Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Uterine Radial Artery Resistance Index Predicts Reproductive Outcome in Women with Recurrent Pregnancy Losses and Thrombophilia.

Bao SH, Chigirin N, Hoch V, Ahmed H, Frempong ST, Zhang M, Ruan JL, Kwak-Kim J.

Biomed Res Int. 2019 Jun 20;2019:8787010. doi: 10.1155/2019/8787010. eCollection 2019.

2.

Resistance of uterine radial artery blood flow was correlated with peripheral blood NK cell fraction and improved with low molecular weight heparin therapy in women with unexplained recurrent pregnancy loss.

Koo HS, Kwak-Kim J, Yi HJ, Ahn HK, Park CW, Cha SH, Kang IS, Yang KM.

Am J Reprod Immunol. 2015 Feb;73(2):175-84. doi: 10.1111/aji.12316. Epub 2014 Oct 23.

PMID:
25339113
3.
4.

Obstetric outcomes of recurrent pregnancy loss patients diagnosed wıth inherited thrombophilia.

Karadağ C, Yoldemir T, Karadağ SD, İnan C, Dolgun ZN, Aslanova L.

Ir J Med Sci. 2017 Aug;186(3):707-713. doi: 10.1007/s11845-017-1569-0. Epub 2017 Feb 7.

PMID:
28176193
5.

Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.

de Jong PG, Kaandorp S, Di Nisio M, Goddijn M, Middeldorp S.

Cochrane Database Syst Rev. 2014 Jul 4;(7):CD004734. doi: 10.1002/14651858.CD004734.pub4. Review.

6.

Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome.

Kaandorp S, Di Nisio M, Goddijn M, Middeldorp S.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD004734. doi: 10.1002/14651858.CD004734.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;7:CD004734.

PMID:
19160241
7.
8.

Non-visualized pregnancy losses are prognostically important for unexplained recurrent miscarriage.

Kolte AM, van Oppenraaij RH, Quenby S, Farquharson RG, Stephenson M, Goddijn M, Christiansen OB; ESHRE Special Interest Group Early Pregnancy.

Hum Reprod. 2014 May;29(5):931-7. doi: 10.1093/humrep/deu042. Epub 2014 Mar 6.

PMID:
24603132
9.

Comparison of uterine artery Doppler in pregnant women with thrombophilia treated by LMWHs and without thrombophilia.

Cok T, Tarim E, Iskender C.

Arch Gynecol Obstet. 2012 Sep;286(3):575-9. doi: 10.1007/s00404-012-2327-1. Epub 2012 Apr 21.

PMID:
22526451
10.

Serum relaxin levels are reduced in pregnant women with a history of recurrent miscarriage, and correlate with maternal uterine artery Doppler indices in first trimester.

Anumba DO, El Gelany S, Elliott SL, Li TC.

Eur J Obstet Gynecol Reprod Biol. 2009 Nov;147(1):41-5. doi: 10.1016/j.ejogrb.2009.07.008. Epub 2009 Aug 19.

11.

ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia--study protocol for a randomized controlled trial.

de Jong PG, Quenby S, Bloemenkamp KW, Braams-Lisman BA, de Bruin JP, Coomarasamy A, David M, DeSancho MT, van der Heijden OW, Hoek A, Hutten BA, Jochmans K, Koks CA, Kuchenbecker WK, Mol BW, Torrance HL, Scheepers HC, Stephenson MD, Verhoeve HR, Visser J, de Vries JI, Goddijn M, Middeldorp S.

Trials. 2015 May 7;16:208. doi: 10.1186/s13063-015-0719-9.

12.

Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.

Brenner B, Hoffman R, Blumenfeld Z, Weiner Z, Younis JS.

Thromb Haemost. 2000 May;83(5):693-7.

PMID:
10823264
13.

Obstetrical outcome of anti-inflammatory and anticoagulation therapy in women with recurrent pregnancy loss or unexplained infertility.

Han AR, Ahn H, Vu P, Park JC, Gilman-Sachs A, Beaman K, Kwak-Kim J.

Am J Reprod Immunol. 2012 Nov;68(5):418-27. doi: 10.1111/j.1600-0897.2012.01178.x. Epub 2012 Jul 27.

PMID:
22835220
14.

Mid-trimester uterine artery Doppler screening as a predictor of adverse pregnancy outcome in high-risk women.

Coleman MA, McCowan LM, North RA.

Ultrasound Obstet Gynecol. 2000 Jan;15(1):7-12.

15.

Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT.

de Vries JI, van Pampus MG, Hague WM, Bezemer PD, Joosten JH; FRUIT Investigators.

J Thromb Haemost. 2012 Jan;10(1):64-72. doi: 10.1111/j.1538-7836.2011.04553.x. Erratum in: J Thromb Haemost. 2015 Feb;13(2):327.

16.

Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial.

Visser J, Ulander VM, Helmerhorst FM, Lampinen K, Morin-Papunen L, Bloemenkamp KW, Kaaja RJ.

Thromb Haemost. 2011 Feb;105(2):295-301. doi: 10.1160/TH10-05-0334. Epub 2010 Nov 23.

PMID:
21103659
17.

Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.

Laskin CA, Spitzer KA, Clark CA, Crowther MR, Ginsberg JS, Hawker GA, Kingdom JC, Barrett J, Gent M.

J Rheumatol. 2009 Feb;36(2):279-87. doi: 10.3899/jrheum.080763).

PMID:
19208560
18.
19.

Chinese herbal medicines for unexplained recurrent miscarriage.

Li L, Dou L, Leung PC, Chung TK, Wang CC.

Cochrane Database Syst Rev. 2016 Jan 14;(1):CD010568. doi: 10.1002/14651858.CD010568.pub2. Review.

PMID:
26760986
20.

Low-molecular-weight heparin plus aspirin versus aspirin alone in pregnant women with hereditary thrombophilia to improve live birth rate: meta-analysis of randomized controlled trials.

Areia AL, Fonseca E, Areia M, Moura P.

Arch Gynecol Obstet. 2016 Jan;293(1):81-86. doi: 10.1007/s00404-015-3782-2. Epub 2015 Jun 10.

PMID:
26059084

Supplemental Content

Support Center